Encapsulation of Exenatide in Poly-(<scp>d,l</scp>-Lactide-Co-Glycolide) Microspheres Produced an Investigational Long-Acting Once-Weekly Formulation for Type 2 Diabetes
Distribution of the number of citations over years.